#

+91-9811715635

  • #
  • #
  • #
#
Global End Stage Renal Disease (ESRD) Market, ESRD Market Research Trends and Forecasts (2016-2020)

Global End Stage Renal Disease (ESRD) Market: Size, Trends and Forecasts (2016-2020)

Publish Date:June 2016
No. of Pages:99

Format : Adobe Reader (PDF) Instant delivery

US$ 1,200.00

Scope of the Report

The report titled “Global End Stage Renal Disease (ESRD) Market: Size, Trends and Forecasts (2016-2020)” provides an in-depth analysis of the global ESRD market with detailed analysis of market size and growth, market share and economic impact of the industry. The report also provides market size of each of the segments of the market on the basis of the treatment opted by the patients along with the detailed overview of the home dialysis market. The report provides detailed market share analysis of the global dialysis market by players as well.

The report also includes the country analysis of the U.S. and Japan for ESRD market. It provides the analysis of ESRD patient volume along with the kidney transplant and dialysis market on the basis of the volume. The segments of the dialysis market are also analyzed in detail.

The report provides detailed regional analysis of North America, Europe, Meddle East and Africa (EMEA), Asia-Pacific and Latin America for the dialysis market. Regional analysis includes market size by volume along with the segments and clinic operators in each region.

Furthermore, the report assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall global ESRD market has also been forecasted for the period 2016-2020, taking into consideration the previous growth patterns, the growth drivers and the current and future trends. The competition in the global dialysis market is stiff and dominated by the big players like FMC. Further, key players of the dialysis market Baxter and Davita are also profiled with their financial information and respective business strategies.

Regional Coverage

- North America
- EMEA
- Asia-Pacific
- Latin America

Country Coverage

- The U.S.
- Japan

Company Coverage

- Fresenius Medical Care
- Baxter International
- Davita Healthcare Partners

Executive Summary

End Stage renal disease (ESRD) occurs when the kidneys are no longer able to carry out their daily functions, requiring either dialysis or transplantation to sustain life. When properly functioning, kidneys act to filter the body of metabolic wastes, which are excreted as urine, and to maintain fluid balance. Chronic kidney failure, a decline in kidney function most often related to diabetes or hypertension, but resulting from other causes as well, including vascular disease, genetic disorders, and exposure to toxic levels of certain drugs. The best strategy for preventing ESRD is to detect chronic kidney failure at the earliest possible stage so that the decline in kidney function can be slowed through the use of medications and tight control of blood sugar and blood pressure levels.

The global ESRD market increased at a significant CAGR during the span of 5 years, i.e. 2010-2015 and projections are made that the market would rise in the next five years i.e. 2016-2020 tremendously. The upsurge in the market was due to the various reasons such as is diabetic nephropathy, genetic diseases, infection, drugs, traumatic injury, major surgery and etc. The market can be segmented on the basis of treatment as kidney transplant and dialysis. The global dialysis market can be segmented on the basis of products and services. On the basis of products, the market is segmented into hemodialysis and peritoneal dialysis while on the basis of services, the market is segmented into in-center dialysis and home dialysis.

The growth drivers for the market are: rise in diabetic and aging population, upsurge in per capita healthcare expenditure along with the emerging countries such as India, China and Brazil. Despite the market is governed by various growth drivers, there are certain challenges faced by the market such as: disparities in the access to renal transplant therapy, less public awareness and negative societal effects.

1. Executive Summary

2. Introduction

2.1 Introduction to Kidney Diseases
2.2 End Stage Renal Disease (ESRD)
2.2.1 Causes of ESRD
2.2.2 Symptoms of ESRD
2.2.3 Diagnosis of ESRD
2.3 Treatment of ESRD
2.3.1 Dialysis Treatment
2.3.2 Kidney Transplantation

3. Global ESRD Market Analysis

3.1 Global ESRD Market by Volume
3.2 Global ESRD Prevalence Rate
3.3 Global ESRD Market by Segments on the Basis of Treatment

4. Country Analysis: ESRD Market

4.1 The U.S. ESRD Market Analysis
4.1.1 The U.S. ESRD Market by Volume
4.1.2 The U.S. ESRD Prevalence Rate
4.1.3 The  U.S. ESRD Market by Causes of Disease
4.2 Japan ESRD Market Analysis
4.2.1 Japan ESRD Market by Volume
4.2.2 Japan ESRD Market by Segments on the Basis of Treatment

5. Kidney Transplant Market Analysis

5.1 Global Kidney Transplant Market by Volume
5.2 Country Analysis of Kidney Transplant Market
5.2.1 The U.S. Kidney Transplant Market by Volume
5.2.2 Japan Kidney Transplant Market by Volume

6. Global Dialysis Market Analysis

6.1 Global Dialysis Market by Value
6.2 Global Dialysis Market by Volume
6.3 Global Dialysis  Market by Segments on the Basis of Products
6.3.1 Global Hemodialysis Market by Volume
6.3.2 Global Peritoneal Dialysis Market by Volume
6.4 Global Dialysis Market by Segments on the Basis of Services
6.5 Global Dialysis Prevalence Rate
6.6 Global Dialysis Market by Region

7. Regional Analysis: Dialysis Market

7.1 North America Dialysis Market Analysis
7.1.1 North America Dialysis Market by Volume
7.1.2 The U.S. Dialysis Market Analysis
The U.S. Dialysis Market by Volume
The U.S. Hemodialysis Market by Volume
The U.S. Peritoneal Dialysis Market by Volume
7.2 EMEA Dialysis Market by Volume
7.3 Asia-Pacific Dialysis Market Analysis
7.3.1 Asia-Pacific Dialysis Market by Volume
7.3.2 Japan Dialysis Market Analysis
Japan Dialysis Market by Volume
Japan Hemodialysis Market by Volume
Japan Peritoneal Dialysis Market by Volume
7.4 Latin America Dialysis Market by Volume
7.5 Regional Dialysis Market by Segments
7.6 Regional Dialysis Clinic Operators

8. Home Dialysis Market Overview

8.1 Introduction to Home Dialysis
8.2 Global Home Dialysis Market by Volume
8.3 Regional Home Dialysis Market by Volume
8.4 The U.S. Home Dialysis Market by Volume
8.5 Japan Home Hemodialysis Market by Volume

9. Market Dynamics

9.1 Growth Drivers
9.1.1 Increase in Diabetic Population
9.1.2 Rising Aging Population
9.1.3 Emerging Markets
9.1.4 Upsurge in Healthcare per Capita Expenditure
9.2 Challenges
9.2.1 Disparities in the Access to Renal Transplant Therapy
9.2.2 Less Public Awareness
9.2.3 Negative Societal Effects
9.3 Market Trends
9.3.1 Health Trends Relating to ESRD
9.3.2 Higher Life Expectancy of ESRD Patients 
9.3.3 Relationship between Mortality and ESRD Treatment

10. Competitive Landscape

10.1 Major Players in the Global Dialysis Market
10.1.1 Dialysis Key Products Group Players
10.1.2 Global Dialysis Market Players by Segments
10.2 Regional Dialysis Market Players
10.2.1 North America and Europe Dialysis Market Players
10.2.2 Asia-Pacific and Latin America Dialysis Market Players

11. Company Profiling

11.1 Fresenius Medical Care AG & Co. KGaA
11.1.1 Business Overview
11.1.2 Financial Overview
11.1.3 Business Strategy

11.2. Baxter International, Inc.
11.2.1 Business Overview
11.2.2 Financial Overview
11.2.3 Business Strategy

11.3 Davita Healthcare Partners Inc.
11.3.1 Business Overview
11.3.2 Financial Overview
11.3.3 Business Strategy
Figure 1: Treatments of ESRD
Figure 2: Types of Dialysis Treatments
Figure 3: Global ESRD Market by Volume; 2010-2015 (Million)
Figure 4: Global ESRD Market by Volume; 2016E-2020E (Million)
Figure 5: Global ESRD Prevalence Rate; 2010-2015E (p.m.p)
Figure 6: Global ESRD Market by Segments; 2015 (%)
Figure 7: The U.S. ESRD Market by Volume; 2010-2015E (Thousand)
Figure 8: The U.S. ESRD Prevalence Rate; 2010-2015E (p.m.p)
Figure 9: The U.S. ESRD Market by Causes of Disease; 2013-2015E (%)
Figure 10: Japan ESRD Market by Volume; 2010-2015E (Thousand)
Figure 11: Japan ESRD Market by Segments; 2013-2015E (%)
Figure 12: Global Kidney Transplant Market by Volume; 2010-2016E (Thousand)
Figure 13: The U.S. Kidney Transplant Market by Volume; 2010-2015E (Thousand)
Figure 14: Japan Kidney Transplant Market by Volume; 2010-2015E (Thousand)
Figure 15: Global Dialysis Market by Value; 2014-2020E (US$ Billion)
Figure 16: Global Dialysis Market by Volume; 2010-2016E (Million)
Figure 17: Global Dialysis Market by Segments on the Basis of Products; 2015 (%)
Figure 18: Global Hemodialysis Market by Volume; 2010-2015 (Million)
Figure 19: Global Peritoneal Dialysis Market by Volume; 2010-2015 (Thousand)
Figure 20: Global Dialysis Market by Segments on the Basis of Services; 2014 (%)
Figure 21: Global Dialysis Prevalence Rate; 2010-2015E (p.m.p)
Figure 22: Global Dialysis Market by Region; 2015 (%)
Figure 23: North America Dialysis Market by Volume; 2010-2015 (Thousand)
Figure 24: The U.S. Dialysis Market by Volume; 2010-2015E (Thousand)
Figure 25: The U.S. Hemodialysis Market by Volume; 2010-2015E (Thousand)
Figure 26: The U.S. Peritoneal Dialysis Market by Volume; 2010-2015E (Thousand)
Figure 27: EMEA Dialysis Market by Volume; 2010-2015 (Thousand)
Figure 28: Asia-Pacific Dialysis Market by Volume; 2010-2015 (Thousand)
Figure 29: Japan Dialysis Market by Volume; 2010-2015E (Thousand)
Figure 30: Japan Hemodialysis Market by Volume; 2010-2015E (Thousand)
Figure 31: Japan Peritoneal Dialysis Market by Volume; 2010-2015E (Thousand)
Figure 32: Latin America Dialysis Market by Volume; 2010-2015 (Thousand)
Figure 33: Regional Dialysis Market by Segments; 2015 (%)
Figure 34: Regional Dialysis Clinic Operators; 2015 (%)
Figure 35: Types of Home Dialysis
Figure 36: Global Home Dialysis Market by Volume; 2012-2015 (Thousand)
Figure 37: Regional Home Dialysis Market by Volume; 2012-2015 (Thousand)
Figure 38: The U.S. Home Dialysis Market by Volume; 201-2015 (Thousand)
Figure 39: Japan Home Hemodialysis Market by Volume; 2010-2015 (Thousand)
Figure 40: Global Diabetic Population; 2011-2040E (Million)
Figure 41: Global Aging Population; 2010-2015E (Million)
Figure 42: Global Emerging Markets; 2015 (%)
Figure 43: Global Healthcare per Capita Expenditure; 2010-2015E 
Figure 44: Global Dialysis Market by Players; 2015 (%)
Figure 45: Global Dialysis Market Players by Segments; 2015 (%)
Figure 46: North America and Europe Dialysis Market by Players; 2015 (%)
Figure 47: Asia-Pacific and Latin America Dialysis Market by Players; 2015 (%)
Figure 48: FMC  Business Segments
Figure 49: FMC Net Revenues; 2011-2015 (US$ Billion)
Figure 50: FMC Net Revenue by Business Segments; 2015 (%)
Figure 51: FMC Net Revenue by Regions; 2015 (%)
Figure 52: Baxter International Business Segments
Figure 53: Baxter International Net Sales; 2011-2015 (US$ Billion)
Figure 54: Baxter International Net Sale by Business Segment; 2015 (%)
Figure 55: Baxter International Net Sales by Regions; 2015 (%)
Figure 56: Davita Healthcare Partners Business Segments
Figure 57: Davita Healthcare Partners Net Revenues; 2011-2015  (US$ Billion)
Figure 58: Davita Healthcare Partners Net Revenue by Business Segment; 2015 (%)
Table 1: Pros and Cons of Various Types of Home Dialysis
Table 2: Global Market Position of Major Players in Dialysis Key Product Groups; 2015